| 英文名稱 |
中文名稱 |
CAS號(hào) |
操作 |
| 8-METHOXY-5-NITROQUINOLINE |
8-METHOXY-5-NITROQUINOLINE |
17012-47-4 |
詳細(xì)
|
| methyl (4-nitro-1H-pyrazol-1-yl)acetate |
(4-硝基-1H-吡唑-1-基)乙酸甲酯 |
6715-84-0 |
詳細(xì)
|
| 5-FLUORO-2,3-DIHYDRO-6-HYDROXY-1H-ISOINDOL-1-ONE |
5-FLUORO-2,3-DIHYDRO-6-HYDROXY-1H-ISOINDOL-1-ONE |
1007455-25-5 |
詳細(xì)
|
| 2,5-DIHYDRO-2-METHYL-5-OXO-1H-PYRAZOLE-3-CARBOXYLIC ACID ETHYL ESTER |
2,5-二氫-2-甲基-5-氧代-1H-吡唑-3-羧酸乙酯 |
40711-34-0 |
詳細(xì)
|
| N-Methyl-4-[7-(4-cyano-3-trifluoromethylphenyl)-8-oxo-6-thioxo-5,7-diazaspiro[3.4]octan-5-yl]-2-fluorobenzamide |
N-甲基-4-[7-(4-氰基-3-三氟甲基苯基)-8-氧代-6-硫酮-5,7-二氮雜螺[3.4]辛烷-5-基]-2-氟苯甲酰胺 |
915087-27-3 |
詳細(xì)
|
| CID44216842 |
KUC103479N-02 |
1222513-26-9 |
詳細(xì)
|
| MLS-573151 |
MLS-573151 |
10179-57-4 |
詳細(xì)
|
| Bevenopran |
676500-67-7 |
676500-67-7 |
詳細(xì)
|
| TLR78 agonist 1 dihydrochloride |
TLR7/8激動(dòng)劑1二鹽酸鹽 |
1620278-72-9 |
詳細(xì)
|
| FL-411 |
2-(4-羥基-3,5-二甲基苯基)-7-甲基-5,6,7,8-四氫吡啶并[4',3':4,5]噻吩并[2,3-D]嘧啶-4(1H)-酮 |
2118944-88-8 |
詳細(xì)
|
| K-756 |
130017-40-2 |
130017-40-2 |
詳細(xì)
|
| NEO2734 (EP31670) |
化合物NEO2734 |
2081072-29-7 |
詳細(xì)
|
| 4-Piperidinecarboxamide, 1-[(4-chlorophenyl)sulfonyl]-N-(4-phenyl-2-thiazolyl)- |
|
923418-24-0 |
詳細(xì)
|
| 2-chloroimidazo[1,2-a]pyridine-3-carbonitrile |
2-氯咪唑并[1,2-A]吡啶-3-甲腈 |
131773-48-3 |
詳細(xì)
|
| BB-22 |
BB-22 |
1400742-42-8 |
詳細(xì)
|
| NGB 2904 |
N-[4-[4-(2,3-Dichlorophenyl)-1-piperazinyl]butyl]-9H-fluorene-2-carboxamide hydrochloride |
189061-11-8 |
詳細(xì)
|
| Ro 5212773 (EPPTB) |
化合物EPPTB |
1110781-88-8 |
詳細(xì)
|
| (4-NITRO-PYRAZOL-1-YL)-ACETIC ACID ETHYL ESTER |
2-(4-硝基-1H-吡唑-1-基)乙酸乙酯 |
39753-81-6 |
詳細(xì)
|
| HS-1371 |
HS1371 |
2158197-70-5 |
詳細(xì)
|
| BAY 2416964 |
AHR antagonist 3 |
2242464-44-2 |
詳細(xì)
|
| MMV674850 |
|
1820874-51-8 |
詳細(xì)
|
| 5-Pyrimidinecarboxaldehyde, 4-amino-2-methyl- (6CI,7CI,8CI,9CI) |
4-氨基-2-甲基嘧啶-5-甲醛 |
73-68-7 |
詳細(xì)
|
| 3,5-Dichloro-2-nitrobenzaldehyde |
3,5-二氯-2-硝基苯甲醛 |
59178-12-0 |
詳細(xì)
|
| 2-Methylsulfanyl-7,8-dihydro-5H-pyrido[4,3-d]pyriMidine -6-carboxylic acid tert-butyl ester |
2-(甲硫基)-7,8-二氫吡啶并[4,3-D]嘧啶-6(5H)-羧酸叔丁酯 |
259809-78-4 |
詳細(xì)
|
| PFI-1 (PF-6405761) |
PFI-1 (PF-6405761) |
1403764-72-6 |
詳細(xì)
|
| LXH254 |
LXH254 |
1800398-38-2 |
詳細(xì)
|
| Grp94inhibitor-1 |
GRP94 |
2234897-35-7 |
詳細(xì)
|
| Samelisant (SUVN-G3031) |
SUVN-G3031 |
1394808-82-2 |
詳細(xì)
|
| SCF29402 |
|
1083418-81-8 |
詳細(xì)
|
| Cedirogant |
4-Piperidineacetic acid, 1-[2,4-dichloro-3-[[7-chloro-5-(trifluoromethyl)-1H-indol-1-yl]methyl]benzoyl]- |
2055496-11-0 |
詳細(xì)
|
| TJ-M2010-5 |
化合物TJ-M2010-5 |
1357471-57-8 |
詳細(xì)
|
| Toceranib |
Toceranib |
356068-94-5 |
詳細(xì)
|
| 2-Chloro-6-hydroxymethyl-pyridin-3-ol |
6-氯-5-羥基吡啶-2-甲醇 |
208519-41-9 |
詳細(xì)
|
| 2-CHLORO-7,8-DIHYDRO-1,7-NAPHTHYRIDIN-8-ONE |
2-氯-1,7-萘啶-8(7H)-酮 |
930303-55-2 |
詳細(xì)
|
| KF-31327 |
KF-31327 |
204077-66-7 |
詳細(xì)
|
| EMPA |
N-ETHYL-2-[(6-METHOXYPYRIDIN-3-YL)-(2-METHYLPHENYL)SULFONYLAMINO]-N-(PYRIDIN-3-YLMETHYL)ACETAMIDE |
680590-49-2 |
詳細(xì)
|
| PCNA-I1 |
PCNA-I1 |
444930-42-1 |
詳細(xì)
|
| RIPA-56 |
RIPA-56 |
1956370-21-0 |
詳細(xì)
|
| 1,3-Benzodioxole-5-acetic acid, 2,2-dimethyl- |
1,3-Benzodioxole-5-acetic acid, 2,2-dimethyl- |
38515-59-2 |
詳細(xì)
|
| CC618 |
化合物CC618 |
1680204-90-3 |
詳細(xì)
|
| GLP-1R modulator L7-028 |
化合物GLP-1R MODULATOR L7-028 |
2648317-95-5 |
詳細(xì)
|
| Palosuran |
ACT 058362; PALOSURAN, |
540769-28-6 |
詳細(xì)
|
| 2-(2-(pyridin-2-yl)disulfanyl)ethanol |
2-[2-(吡啶基)連硫基]乙醇 |
111625-28-6 |
詳細(xì)
|
| (E)-2-cyano-3-cyclopropylacrylic acid |
(E)-2-CYANO-3-CYCLOPROPYLACRYLIC ACID |
98895-60-4 |
詳細(xì)
|
| 4-(((Tert-Butyldimethylsilyl)Oxy)Methyl)Phenol |
126070-20-0 |
126070-20-0 |
詳細(xì)
|
| SR9238 |
1416153-62-2 |
1416153-62-2 |
詳細(xì)
|
| 3,5-Difluoro-4-methylbenzaldehyde |
3,5-Difluoro-4-methylbenzaldehyde |
1429902-14-6 |
詳細(xì)
|
| SBI-797812 |
SBI-797812 |
2237268-08-3 |
詳細(xì)
|
| Bersacapavir (JNJ-56136379) |
化合物 T32308 |
1638266-40-6 |
詳細(xì)
|
| 4-(1,5-DIMETHYL-3-OXO-2-PHENYL-2,3-DIHYDRO-1H-PYRAZOL-4-YLSULFAMOYL)-BENZOIC ACID |
4-[(1,5-二甲基-3-氧代-2-苯基-2,3-二氫-1H-吡唑-4-基)氨磺酰基]苯甲酸 |
31816-70-3 |
詳細(xì)
|
| 6-amino-4-ethyl-2H-1,4-benzoxazin-3(4H)-one(SALTDATA: FREE) |
6-氨基-4-乙基-2H-苯并[B][1,4]惡嗪-3(4H)-酮 |
103361-44-0 |
詳細(xì)
|
| SGC-CBP30 |
SGC-CBP30 |
1613695-14-9 |
詳細(xì)
|
| Bromosporine |
C17H20N6O4S |
1619994-69-2 |
詳細(xì)
|
| 1-(tert-Butyl)-1H-pyrazole-3-carboxylic acid |
1-(叔丁基)-1H-吡唑-3-羧酸 |
942508-00-1 |
詳細(xì)
|
| PLX51107 |
化合物PLX51107 |
1627929-55-8 |
詳細(xì)
|
| GLX351322 |
CS-2871 |
835598-94-2 |
詳細(xì)
|
| Velufenacin |
化合物VELUFENACIN |
1648737-78-3 |
詳細(xì)
|
| SCR130 |
1,7,9-Triazaspiro[4.5]dec-1-ene-6,10-dione, 2,4-bis(4-chlorophenyl)-8-thioxo- |
2377858-38-1 |
詳細(xì)
|
| 2-(3-nitrophenyl)-1,3,4-oxadiazole |
2-(3-nitrophenyl)-1,3,4-oxadiazole |
5565-72-0 |
詳細(xì)
|
| C646 |
C646 |
328968-36-1 |
詳細(xì)
|
| 2-Methyl-4-(4,4,5,5-tetramethyl-[1,3,2]dioxaborolan-2-yl)-2,3-dihydro-isoindol-1-one |
N-甲基-1-異吲哚酮-5-硼酸頻哪醇酯 |
1221239-09-3 |
詳細(xì)
|
| 4E2RCat |
432499-63-3 |
432499-63-3 |
詳細(xì)
|
| SB-222200 |
3-甲基-2-苯基-N-((1S)-1-苯基丙基)喹啉-4-甲酰胺 |
174635-69-9 |
詳細(xì)
|
| JAK1-IN-8 |
JAK1-IN-8 |
1973485-18-5 |
詳細(xì)
|
| NSC 23766 TETRAHYDROCHLORIDE |
N6-[2-[[4-(二乙基氨基)-1-甲基丁基]氨基]-6-甲基-4-嘧啶基]-2-甲基-4,6-喹啉二胺 |
733767-34-5 |
詳細(xì)
|
| Dalpiciclib free base |
Pyrido[2,3-d]pyrimidin-7(8H)-one, 6-acetyl-8-cyclopentyl-5-methyl-2-[[5-(4-piperidinyl)-2-pyridinyl]amino]- |
1637781-04-4 |
詳細(xì)
|
| Quinoline, 8-methoxy-7-nitro- |
|
281658-02-4 |
詳細(xì)
|
| Talnetant |
TALNETANT |
174636-32-9 |
詳細(xì)
|
| ML-141 |
ML 141 |
71203-35-5 |
詳細(xì)
|
| RO495 (CS-2667) |
CS-2667 |
1258296-60-4 |
詳細(xì)
|
| 2-Methyl-6-(4,4,5,5-tetraMethyl-[1,3,2]dioxaborolan-2-yl)-2,3-dihydro-isoindol-1-one |
2-甲基-6-(4,4,5,5-四甲基-1,3,2-二氧硼戊烷-2-基)異吲哚啉-1-酮 |
1313399-38-0 |
詳細(xì)
|
| UNC1215 |
UNC1215 |
1415800-43-9 |
詳細(xì)
|
| MCP110 |
化合物 T24437 |
521310-51-0 |
詳細(xì)
|
| 5-(2-THIENYL)PENTANOIC ACID |
5-(2-噻吩基)戊酸 |
21010-06-0 |
詳細(xì)
|
| Furo[2,3-c]pyridine-5-methanol (9CI) |
2,3- C]吡啶,5 - 羥甲基呋喃 |
478148-60-6 |
詳細(xì)
|
| 6-NITRO-2H-PYRIDO[3,2-B][1,4]OXAZIN-3(4H)-ONE |
6-硝基-2H-吡啶并[3,2-B][1,4]惡嗪-3(4H)-酮 |
337463-64-6 |
詳細(xì)
|
| 2-Bromo-3-chloroimidazo[1,2-a]pyridine |
2-溴-3-氯-1H-咪唑[1,2-A]吡啶 |
1159511-19-9 |
詳細(xì)
|
| FIPI |
FIPI |
939055-18-2 |
詳細(xì)
|
| Mibampator(LY451395) |
MIBAMPATOR |
375345-95-2 |
詳細(xì)
|
| SAPA-1j |
SMS1-IN-1 |
1807943-38-9 |
詳細(xì)
|
| Pomalidomide 4'-PEG1-amine hydrochloride |
4-[(2-(2-Aminoethoxy)ethyl)amino]-2-(2,6-dioxopiperidin-3-yl)isoindoline-1,3-dione HCl |
2154342-56-8 |
詳細(xì)
|
| Ninerafaxstat |
|
2254741-41-6 |
詳細(xì)
|
| MMV666810 |
化合物MMV666810 |
1450666-97-3 |
詳細(xì)
|
| 3-Phenylazetidin-3-ol |
3-苯基氮雜環(huán)丁烷-3-醇 |
25566-04-5 |
詳細(xì)
|
| ETHYL 2-(6'-CYANO-5'-OXO-3',5'-DIHYDRO-2'H-SPIRO[[1,3]DIOXOLANE-2,1'-INDOLIZINE]-7'-YL)ACETATE |
2-(6-氰基-5-氧代-2,3-二氫-5H-螺[吲哚嗪-1,2'-[1,3]二氧戊環(huán)] -7-基)乙酸乙酯 |
58610-65-4 |
詳細(xì)
|
| ATH686 |
化合物ATH 686 |
853299-52-2 |
詳細(xì)
|
| 5-broMo-1-Methyl-1H-pyrazole-3-carboxylic acid |
5-溴-1-甲基-1H-吡唑-3-羧酸 |
1222174-93-7 |
詳細(xì)
|
| Compound 3i (666-15) |
1433286-70-4 |
1433286-70-4 |
詳細(xì)
|
| GSK-2033 |
GSK 2033 |
1221277-90-2 |
詳細(xì)
|
| 6-Oxo-5-trifluoromethyl-1,6-dihydro-pyridine-2-carboxylic acid methyl ester |
6-羥基-5-(三氟甲基)吡啶甲酸甲酯 |
1006364-88-0 |
詳細(xì)
|
| GW 590735 |
化合物GW590735 |
343321-96-0 |
詳細(xì)
|
| VERBENONE |
馬鞭草烯酮 |
18309-32-5 |
詳細(xì)
|
| 2-BROMOMETHYL-4-NITROPYRIDINE |
2-溴甲基-4-硝基吡啶 |
442910-43-2 |
詳細(xì)
|
| 5-tert-butylbenzo[b]thiophene |
5-叔丁基苯并[B]噻吩 |
17515-00-3 |
詳細(xì)
|
| Benzeneacetic acid, 2-chloro-6-fluoro-α-methyl- |
2-(2-氯-6-氟苯基)丙酸 |
1083172-73-9 |
詳細(xì)
|
| methyl 5-(tert-butyl)-1,2,4-oxadiazole-3-carboxylate |
5-(叔丁基)-1,2,4-噁二唑-3-羧酸甲酯 |
2111292-26-1 |
詳細(xì)
|
| JAK-IN-14 |
化合物JAK-IN-14 |
1973485-06-1 |
詳細(xì)
|
| 4-AMINO-8-METHOXYLQUINOLINE |
4-AMINO-8-METHOXYLQUINOLINE |
220844-65-5 |
詳細(xì)
|
| 3-(3-HYDROXY-PHENYL)-PIPERAZINE-1-CARBOXYLIC ACID TERT-BUTYL ESTER |
1-BOC-3-(3-羥苯基)哌嗪 |
889956-76-7 |
詳細(xì)
|
| 1H-Pyrazole-4-carboxylicacid,1-ethyl-,hydrazide(9CI) |
1-乙基-4-吡唑卡巴肼 |
512809-51-7 |
詳細(xì)
|